CSMD1 and central nervous system cancer: A total of 1500 patients with glioma were analyzed from three different cohorts including The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Chinese Glioma Genome Atlas (CGGA) revealing that downregulation of CSMD1 is linked to a poor prognosis and the activation of the neuroinflammation signaling pathway.